Sort   by:  
 Page size 
UnknownCachexia Phenotyping Through Morphofunctional Assessment and Mitocondrial Biomarkers (GDF-15 and PGC-1α) in Idiopathic Pulmonary Fibrosis.
Not available
S-EPMC12430740 | biostudies-literature
UnknownRectus Femoris Cross-Sectional Area and Phase Angle asPredictors of 12-Month Mortality in Idiopathic Pulmonary Fibrosis Patients.
Not available
S-EPMC10609753 | biostudies-literature
UnknownThe role of astrocytes in depression, its prevention, and treatment by targeting astroglial gliotransmitter release.
Not available
S-EPMC11572930 | biostudies-literature
UnknownCluster randomized trial in smoking cessation with intensive advice in diabetic patients in primary care. ITADI Study.
Not available
S-EPMC2825223 | biostudies-literature
UnknownQuizartinib for Newly Diagnosed <i>FLT3</i>-Internal Tandem Duplication-Negative AML: The Randomized, Double-Blind, Placebo-Controlled, Phase II QUIWI Study.
Not available
S-EPMC12736402 | biostudies-literature
UnknownComparison of seven prognostic tools to identify low-risk pulmonary embolism in patients aged <50 years.
Not available
S-EPMC6934558 | biostudies-literature
UnknownEffects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes.
Not available
S-EPMC9792409 | biostudies-literature
UnknownSafety of the PCSK9 inhibitor alirocumab: insights from 47 296 patient-years of observation.
Not available
S-EPMC11249957 | biostudies-literature
UnknownPrevalence, associated factors and outcomes of pressure injuries in adult intensive care unit patients: the DecubICUs study.
Not available
S-EPMC7880913 | biostudies-literature
UnknownApolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab.
Not available
S-EPMC9422774 | biostudies-literature
Sort   by:  
 Page size